BNET Industries

Last Fiscal Year Sales:$3.7B
  • Public
  • US
Dow Jones Description

This section contains certain forward-looking statements that are subject to various risks and uncertainties. Such statements include, without limitation, discussions concerning the outlook of Fresenius Medical Care Holdings, Inc. (collectively with all its direct and indirect subsidiaries, the "Company"), government reimbursement, future plans and management's expectations regarding future performance. Actual results could differ materially from those contained in these forward-looking statements due to certain factors including, without limitation, changes in business, economic and competitive conditions, regulatory reforms, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, the realization of anticipated tax deductions, and the availability of financing. These and other risks and uncertainties, which are more fully described elsewhere in this 2002 Form 10-K and in the Company's reports filed from time to time with the Securities and Exchange Commission (the "Commission") could cause the Company's results to differ materially from the results that have been or may be projected by or on behalf of the Company.

Contact Information

Two Ledgemont Center

95 Hayden Ave

Lexington, Massachusetts 02420

6174029000

NAICS Code Surgical and Medical Instrument Manufacturing: 339112

News & Analysis

Filter by

fresenius medical care holdings inc. - All News and Analysis

  • Get a Deep Insight into the World Artificial Organs Market

    - 2008-03-26

    Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue. World Artificial Organs Market This report analyzes the worldwide markets for Artificial Organs in US$ Million. The major product segments analyzed are Artificial Heart, Artificial Kidneys, Artificial Liver, Artificial...

  • Fresenius Medical Care Extends Senior Note Exchange Offer

    - 2008-01-25

    BAD HOMBURG, Germany -- Fresenius Medical Care AG & Co. KGaA ("the Company") today announced that its wholly-owned subsidiary, FMC Finance III S.A. had extended the expiration date of its Exchange Offer to the holders of its 6 7/8% Senior Notes due 2017. The Notes will be unconditionally guaranteed by...

  • U.S. Joins Suit Against Renal Care Group Alleging False Billings to Medicare for Home Care Renal Dialysis

    - 2007-07-17

    To: NATIONAL EDITORS Contact: U.S. Department of Justice, +1-202-514-2007, TDD +1-202-514-1888 WASHINGTON, July 17 /PRNewswire-USNewswire/ -- The United Stateshas intervened in a whistleblower suit accusing Renal Care Group Inc.RCG and Renal Care Group Supply Company RCGSC of fraudulentlybilling Medicare, the Justice Department announced today. The suitalleges that RCG and...

  • Fresenius Medical Care Successfully Placed 10 Year Senior Notes in the Amount of US$ 500 million

    - 2007-06-26

    BAD HOMBURG, Germany -- Fresenius Medical Care AG & Co. KGaA ("the Company"), the world's largest provider of Dialysis Products and Services, today announced the pricing of Senior Notes due 2017 in the amount of US$ 500 million. The coupon will be 6 7/8%. Proceeds will be used to reduce...

  • Sovereign Investment Company Completes $9 Million Acquisition of Six Preferred Medical Group Properties

    - 2007-05-07

    PRINCETON, N.J. -- Sovereign Investment Company, one of the largest and fastest growing private equity investors providing sale-leaseback capital, announced that it has acquired six properties worth $9 million from Preferred Medical Group, a developer of medical office centers in Georgia and Florida. All of the acquired units...

advertisement
Glass Door
advertisement